Adocia: New phase Ib start with BC lispro

BUY, Fair Value EUR113 (+52%)
News published on September Wednesday 30, 2015
Share on

A new phase Ib study is starting with BC lispro in type II diabetes. Lilly, whose Diabetes franchise has strengthened a lot with Trulicity and Jardiance recently, shows strong commitment to BC lispro. It is still the prime asset of Adocia. We still expect a phase III start in H1 2016.

For more information, please contact 

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities